Home › Atherosclerosis › Kansas
Atherosclerosis clinical trials in Kansas
4 studies for Atherosclerosis are looking for participants at sites in Kansas.
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Midwest Heart & Vascular Specialists, LLC, Overland Park
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 5, 2026 · NCT07521007Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Cotton O'Neil Clinical Research Center, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Kansas Nephrology Physicians, PA, Wichita
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.